Literature DB >> 27808264

Alzheimer disease: BACE1 inhibition could block CSF tau increase.

Hemi Malkki.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 27808264     DOI： 10.1038/nrneurol.2016.170

Source DB:  PubMed          Journal:  Nat Rev Neurol        ISSN： 1759-4758            Impact factor:   42.937


× No keyword cloud information.
  1 in total

1.  Prevention of tau increase in cerebrospinal fluid of APP transgenic mice suggests downstream effect of BACE1 inhibition.

Authors:  Juliane Schelle; Lisa M Häsler; Jens C Göpfert; Thomas O Joos; Hugo Vanderstichele; Erik Stoops; Eva-Maria Mandelkow; Ulf Neumann; Derya R Shimshek; Matthias Staufenbiel; Mathias Jucker; Stephan A Kaeser
Journal:  Alzheimers Dement       Date:  2016-10-14       Impact factor: 21.566
  1 in total
  2 in total

1.  Plasma long non-coding RNA BACE1 as a novel biomarker for diagnosis of Alzheimer disease.

Authors:  Liang Feng; Yu-Ting Liao; Jin-Cai He; Cheng-Long Xie; Si-Yan Chen; Hui-Hui Fan; Zhi-Peng Su; Zhen Wang
Journal:  BMC Neurol       Date:  2018-01-09       Impact factor: 2.474

2.  Computational Approach to Investigating Key GO Terms and KEGG Pathways Associated with CNV.

Authors:  YuanYuan Luo; Yan Yan; Shiqi Zhang; Zhen Li
Journal:  Biomed Res Int       Date:  2018-04-11       Impact factor: 3.411
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.